WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
151 hedge funds and large institutions have $2.42B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 66 reducing their positions, and 29 closing their positions.
40% more funds holding in top 10
Funds holding in top 10: 10 → 14 (+4)
2% less capital invested
Capital invested by funds: $2.48B → $2.42B (-$59.2M)
7% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 29
2% less funds holding
Funds holding: 154 → 151 (-3)
32% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 66
61% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $26.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCA
Taconic Capital Advisors
New York
|
+$88.6M |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$80.9M |
| 3 |
O
OppenheimerFunds
New York
|
+$73.1M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$55.2M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$54.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$110M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$77.1M |
| 3 |
CGI
Comgest Global Investors
Paris,
France
|
-$69.7M |
| 4 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$69.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$44.4M |
WX Hedge Fund Activity: Q3 2015 in Review
151 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q3 2015, worth a combined $2.42B — down 2.4% from $2.48B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of WX and 27 opened new positions — a net loss of 2 holders — while 66 trimmed existing stakes and 45 added.
The largest buyer was Taconic Capital Advisors, adding an estimated $88.6M. The largest seller was Fidelity International, cutting an estimated $110M.
- 151 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q3 2015, down from 154 in Q2 2015.
- Funds reported $2.42B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q3 2015, down 2.4% quarter-over-quarter.
- 27 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q3 2015 and 29 closed out, a net change of -2 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q3 2015 was Taconic Capital Advisors, an estimated $88.6M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q3 2015 was Fidelity International, an estimated $110M sold.
Based on aggregated 13F filings for Q3 2015.